A detailed history of Thrivent Financial For Lutherans transactions in Abbott Laboratories stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 458,057 shares of ABT stock, worth $53.5 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
458,057
Previous 479,241 4.42%
Holding current value
$53.5 Million
Previous $49.8 Million 4.87%
% of portfolio
0.1%
Previous 0.1%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$100.07 - $118.13 $2.12 Million - $2.5 Million
-21,184 Reduced 4.42%
458,057 $52.2 Million
Q2 2024

Aug 13, 2024

BUY
$100.73 - $112.44 $2.06 Million - $2.3 Million
20,480 Added 4.46%
479,241 $49.8 Million
Q1 2024

May 14, 2024

SELL
$109.52 - $120.96 $12.2 Million - $13.5 Million
-111,385 Reduced 19.54%
458,761 $52.1 Million
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $419,383 - $513,360
4,650 Added 0.82%
570,146 $62.8 Million
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $2.74 Million - $3.29 Million
28,691 Added 5.34%
565,496 $54.8 Million
Q2 2023

Aug 14, 2023

SELL
$100.78 - $112.29 $1.05 Million - $1.17 Million
-10,408 Reduced 1.9%
536,805 $58.5 Million
Q1 2023

May 17, 2023

SELL
$96.86 - $114.01 $2.19 Million - $2.58 Million
-22,601 Reduced 3.97%
547,213 $55.4 Million
Q4 2022

Feb 08, 2023

SELL
$95.06 - $111.52 $10.8 Million - $12.6 Million
-113,394 Reduced 16.6%
569,814 $62.6 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $2.44 Million - $2.83 Million
25,268 Added 3.84%
683,208 $66.1 Million
Q2 2022

Aug 16, 2022

BUY
$102.07 - $123.37 $14.8 Million - $17.9 Million
145,122 Added 28.3%
657,940 $71.5 Million
Q1 2022

May 13, 2022

BUY
$114.02 - $139.04 $31 Million - $37.8 Million
271,635 Added 112.63%
512,818 $61.1 Million
Q4 2021

Feb 16, 2022

SELL
$115.53 - $141.46 $3.88 Million - $4.76 Million
-33,625 Reduced 12.24%
241,183 $33.3 Million
Q3 2021

Nov 15, 2021

BUY
$116.66 - $129.06 $3.36 Million - $3.72 Million
28,804 Added 11.71%
274,808 $32.5 Million
Q2 2021

Sep 24, 2021

BUY
$105.79 - $124.53 $1.01 Million - $1.19 Million
9,561 Added 4.04%
246,004 $28.5 Million
Q2 2021

Aug 19, 2021

SELL
$105.79 - $124.53 $14.1 Million - $16.6 Million
-133,407 Reduced 36.07%
236,443 $27.4 Million
Q1 2021

May 17, 2021

SELL
$108.84 - $128.23 $8.8 Million - $10.4 Million
-80,818 Reduced 17.93%
369,850 $44.3 Million
Q4 2020

Feb 16, 2021

SELL
$105.0 - $114.42 $2.13 Million - $2.33 Million
-20,325 Reduced 4.32%
450,668 $49.3 Million
Q3 2020

Nov 10, 2020

SELL
$91.64 - $111.29 $7.02 Million - $8.52 Million
-76,592 Reduced 13.99%
470,993 $51.3 Million
Q2 2020

Aug 12, 2020

BUY
$76.57 - $98.0 $22,358 - $28,616
292 Added 0.05%
547,585 $49.6 Million
Q1 2020

May 15, 2020

BUY
$62.82 - $91.86 $3.36 Million - $4.91 Million
53,498 Added 10.83%
547,293 $43.2 Million
Q4 2019

Feb 13, 2020

SELL
$78.51 - $87.4 $78.7 Million - $87.6 Million
-1,002,713 Reduced 67.0%
493,795 $42.9 Million
Q3 2019

Nov 14, 2019

SELL
$81.84 - $88.74 $10.4 Million - $11.3 Million
-127,508 Reduced 7.85%
1,496,508 $125 Million
Q2 2019

Aug 13, 2019

BUY
$72.88 - $85.0 $27.7 Million - $32.3 Million
380,062 Added 30.55%
1,624,016 $137 Million
Q1 2019

May 14, 2019

BUY
$66.22 - $80.06 $72.5 Million - $87.7 Million
1,094,841 Added 734.24%
1,243,954 $99.4 Million
Q4 2018

Feb 15, 2019

BUY
$65.56 - $74.27 $158,261 - $179,287
2,414 Added 1.65%
149,113 $10.8 Million
Q3 2018

Nov 15, 2018

BUY
$60.81 - $73.36 $126,910 - $153,102
2,087 Added 1.44%
146,699 $10.8 Million
Q2 2018

Aug 14, 2018

SELL
$57.57 - $63.54 $5.07 Million - $5.6 Million
-88,068 Reduced 37.85%
144,612 $8.82 Million
Q1 2018

May 08, 2018

BUY
$56.27 - $63.62 $8.3 Million - $9.38 Million
147,476 Added 173.09%
232,680 $13.9 Million
Q4 2017

Feb 14, 2018

BUY
$53.68 - $57.47 $260,670 - $279,074
4,856 Added 6.04%
85,204 $4.86 Million
Q3 2017

Nov 14, 2017

BUY
$48.06 - $53.64 $3.86 Million - $4.31 Million
80,348
80,348 $4.29 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.